Week 3: Assgn: 1 Prescribing For Children And Adolescents

Week 3: Special Considerations Related to Prescribing for Children and AdolescentsNameCollege of Nursing-PMHNP, Walden UniversityNRNP-6665C: Psychiatric Mental Health Nurse Practitioner Care Across the Lifespan I Dr.DatePlan of care for Children and Adolescents with Bipolar DisorderThe purpose of this paper is to present current data for providing appropriate treatments for children and adolescents with Bipolar Disorder. Discussion will entail recommendations for an FDA-approved drug, an off-label drug and a nonpharmacological intervention for the plan of care with children and adolescents with bipolar disorder. FDA-approved DrugsOne of the recommended FDA-approved drugs for children and adolescents 12 years and older is lithium. The symptoms associated with bipolar disorder are mania and depression. Lithium helps children that have an elevated behavior that presents as increased activity and expression that can rapidly change from euphoric to agitation. Children with severe symptomology will have a greater probability of requiring additional support with care as psychotherapy activities. Children that are bipolar have an increased risk of suicide attempts. Lithium is the forerunner for effective treatment in risk reduction for pediatrics. Lithium also proves to have a high tolerability. The